Life Technologies

Life Technologies Parkinson’s disease cell models—part 3

Issue link: http://life-technologies.uberflip.com/i/368629

Contents of this Issue

Navigation

Page 24 of 33

25 Life Technologies ™ | lifetechnologies.com/parkinsons The Ion Proton ™ Sequencer was used to evaluate potential off-target effects caused by TAL editing. Learn more at lifetechnologies.com/proton Instrument highlight—Ion Proton ™ Sequencer Screening for off-target modifications in the edited MSA lines To determine whether TAL-based editing caused any unintended indels at positions other than the target sites, we sequenced the exomes of the parental and edited lines using the Ion Proton ™ Sequencer. An Ion Reporter ™ Software analysis of the sequencing results revealed only six potential off-target indels in the edited MSA lines, all of which were present in homopolymer regions. Manual inspection of the sequencing reads at these six positions revealed the indels were likely false positives. Sanger sequencing was performed and showed that the same sequences were present in both unedited parental and edited MSA lines. In conclusion, no off-target indels were detected in the exomes of the two edited MSA lines. Results

Articles in this issue

Links on this page

view archives of Life Technologies - Life Technologies Parkinson’s disease cell models—part 3